Stefan Datz
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Materials Chemistry top 10%
- Covalent Organic Framework Applications
- Mesoporous Materials and Catalysis
Papers in
-
- Nanoparticle-Based Drug Delivery 8
-
- Mesoporous Materials and Catalysis 2
- Covalent Organic Framework Applications 1
- Co-authors
- Thomas Bein (11 shared papers)Christian Argyo (5 shared papers)Hanna Engelke (4 shared papers)Oliver Eickelberg (4 shared papers)Silke Meiners (4 shared papers)Sabine van Rijt (4 shared papers)Deniz A. Bölükbas (4 shared papers)Torben Sick (1 shared paper)
- Journals
- Nanoscale (3 papers)Advanced Therapeutics (2 papers)ACS Nano (2 papers)Journal of the American Chemical Society (1 paper)Chemical Communications (1 paper)
- Partner nations
- GermanyUnited StatesGreece
In The Last Decade
Stefan Datz
12 papers receiving 838 citations
Peers
Comparison fields: 5 of 55
- Biomaterials 377
- Materials Chemistry 326
- Pharmaceutical Science 34
- Biomedical Engineering 136
- Drug Discovery 1
Countries citing papers authored by Stefan Datz
This map shows the geographic impact of Stefan Datz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Datz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Datz more than expected).
Fields of papers citing papers by Stefan Datz
This network shows the impact of papers produced by Stefan Datz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Datz. The network helps show where Stefan Datz may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Datz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 193 | |
| 2 | 2015 | 172 | |
| 3 | 2021 | 163 | |
| 4 | 2015 | 139 | |
| 5 | 2015 | 46 | |
| 6 | 2015 | 42 | |
| 7 | 2016 | 41 | |
| 8 | 2018 | 31 | |
| 9 | 2020 | 13 | |
| 10 | 2020 | 10 | |
| 11 | 2016 | 8 | |
| 12 | 2020 | 1 |
About Stefan Datz
Stefan Datz is a scholar working on Biomaterials, Materials Chemistry, Cancer Research, Inorganic Chemistry and Immunology, having authored 12 papers that have together received 859 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), Mesoporous Materials and Catalysis (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Cancer and biochemical research (1 paper), Inhalation and Respiratory Drug Delivery (1 paper), Covalent Organic Framework Applications (1 paper), Inorganic Chemistry and Materials (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Biomaterials (377 citations), Materials Chemistry (326 citations), Pharmaceutical Science (34 citations), Biomedical Engineering (136 citations) and Drug Discovery (1 citation). Stefan Datz has collaborated with scholars based in Germany, United States and Greece. Frequent co-authors include Thomas Bein, Christian Argyo, Hanna Engelke, Oliver Eickelberg, Silke Meiners, Sabine van Rijt, Deniz A. Bölükbas, Torben Sick, Achim Hartschuh and Markus Döblinger. Their work appears in journals such as Nanoscale, Advanced Therapeutics, ACS Nano, Journal of the American Chemical Society and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.